Atriance (nelarabine) is an antimetabolite chemotherapy medication used to treat T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL)
Atriance (nelarabine) is an antimetabolite chemotherapy medication used to treat T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL)